Related Experiment Videos
[Familial Mediterranean fever]
J O Steiss1, J Wiemann, A Rutz
1Zentrum für Kinderheilkunde und Jugendmedizin, Justus-Liebig-Universität Giessen.
Klinische Padiatrie
|April 18, 2001
Summary
Familial Mediterranean fever (FMF) is a genetic disorder causing febrile attacks. Early FMF gene investigation and colchicine treatment can prevent severe complications like amyloidosis.
Area of Science:
- Genetics
- Internal Medicine
Background:
- Familial Mediterranean fever (FMF) is an inherited autoinflammatory disorder.
- Characterized by recurrent febrile attacks, abdominal pain, pleuritis, or arthritis.
- Predominantly affects Mediterranean and Middle Eastern ethnic groups.
- Amyloidosis is a severe complication, potentially leading to chronic renal failure.
Observation:
- A 10-year-old Turkish boy presented with recurrent acute abdominal pain and elevated white blood cell count.
- Molecular analysis confirmed a mutation in the FMF gene.
- The patient experienced symptom resolution after initiating colchicine therapy.
Findings:
- Genetic investigation of the FMF gene enables early diagnosis of Familial Mediterranean fever.
- Identification of FMF gene mutations is crucial for timely intervention.
Implications:
- Early diagnosis and treatment with colchicine can prevent the development of amyloidosis.
- Colchicine therapy is effective in managing FMF symptoms and preventing long-term complications.
- Genetic screening for FMF mutations is recommended in individuals with suggestive clinical findings.